(Q42215035)

English

Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model.

scientific article published on 15 May 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24833752%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Activity of colistin combined with doripenem at clinically relevant concentrations against multidrug-resistant Pseudomonas aeruginosa in an in vitro dynamic biofilm model (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24833752%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

0 references

multiple drug resistance

1 reference

based on heuristic

inferred from title

Pseudomonas aeruginosa

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24833752%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24833752%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24833752%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Phillip J Bergen

3

object named as

Phillip J Bergen

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24833752%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

5

object named as

Anima Poudyal

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24833752%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

8

object named as

Javier Ariza

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24833752%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

author name string

Jaime Lora-Tamayo

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24833752%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Xianling Luo

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24833752%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Heidi Y Yu

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24833752%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

language of work or name

0 references

publication date

15 May 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24833752%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Journal of Antimicrobial Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24833752%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

69

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24833752%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24833752%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

2434-2442

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24833752%20AND%20SRC:MED&resulttype=core&format=json

18 March 2020

Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Drugs for bad bugs: confronting the challenges of antibacterial discovery

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Clinical significance of microbial infection and adaptation in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Management of a multidrug-resistant Pseudomonas aeruginosa infected total knee arthroplasty using colistin. A case report and review of the literature

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Pseudomonas aeruginosa biofilm formation and slime excretion on antibiotic-loaded bone cement

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Colistin in the 21st century

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Polymyxins revisited

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Application of a loading dose of colistin methanesulfonate in critically ill patients: population pharmacokinetics, protein binding, and prediction of bacterial kill

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Pharmacokinetic/pharmacodynamic investigation of colistin against Pseudomonas aeruginosa using an in vitro model

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Clinically relevant plasma concentrations of colistin in combination with imipenem enhance pharmacodynamic activity against multidrug-resistant Pseudomonas aeruginosa at multiple inocula

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Comparison of once-, twice- and thrice-daily dosing of colistin on antibacterial effect and emergence of resistance: studies with Pseudomonas aeruginosa in an in vitro pharmacodynamic model.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Synergistic killing of multidrug-resistant Pseudomonas aeruginosa at multiple inocula by colistin combined with doripenem in an in vitro pharmacokinetic/pharmacodynamic model

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Activity of colistin against heteroresistant Acinetobacter baumannii and emergence of resistance in an in vitro pharmacokinetic/pharmacodynamic model.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

In vitro antimicrobial activity and mutant prevention concentration of colistin against Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

fAUC/MIC is the most predictive pharmacokinetic/pharmacodynamic index of colistin against Acinetobacter baumannii in murine thigh and lung infection models.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Intrathecal colistin for treatment of highly resistant Pseudomonas ventriculitis. Case report and review of the literature

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Outcome of antimicrobial therapy in documented biofilm-associated infections: a review of the available clinical evidence.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Biofilms: microbial life on surfaces

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Bacterial biofilms: a common cause of persistent infections

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Mechanisms of biofilm resistance to antimicrobial agents

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Clinically feasible biofilm susceptibility assay for isolates of Pseudomonas aeruginosa from patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Antibiotic resistance of bacteria in biofilms

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Systematic review and meta-analysis of in vitro synergy of polymyxins and carbapenems

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Colistin-tobramycin combinations are superior to monotherapy concerning the killing of biofilm Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Tolerance to the antimicrobial peptide colistin in Pseudomonas aeruginosa biofilms is linked to metabolically active cells, and depends on the pmr and mexAB-oprM genes

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Differentiation and distribution of colistin- and sodium dodecyl sulfate-tolerant cells in Pseudomonas aeruginosa biofilms.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

In-vitro bactericidal activity of colistin against biofilm-associated Pseudomonas aeruginosa and Acinetobacter baumannii

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Nosocomial outbreak of a non-cefepime-susceptible ceftazidime-susceptible Pseudomonas aeruginosa strain overexpressing MexXY-OprM and producing an integron-borne PSE-1 betta-lactamase.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Stability of colistin and colistin methanesulfonate in aqueous media and plasma as determined by high-performance liquid chromatography.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Model system for growing and quantifying Streptococcus pneumoniae biofilms in situ and in real time

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Statistical assessment of a laboratory method for growing biofilms.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Activities of high-dose daptomycin, vancomycin, and moxifloxacin alone or in combination with clarithromycin or rifampin in a novel in vitro model of Staphylococcus aureus biofilm

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Doripenem monohydrate, a broad-spectrum carbapenem antibiotic

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Effectiveness and safety of colistin for the treatment of multidrug-resistant Pseudomonas aeruginosa infections.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Attenuation of colistin bactericidal activity by high inoculum of Pseudomonas aeruginosa characterized by a new mechanism-based population pharmacodynamic model

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant Pseudomonas aeruginosa in an in vitro pharmacodynamic model

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa.

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic backgrounds emerge in mucA and/or lasR mutants

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Pseudomonas aeruginosa and the in vitro and in vivo biofilm mode of growth

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Community structure and metabolism through reconstruction of microbial genomes from the environment

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Rapid necrotic killing of polymorphonuclear leukocytes is caused by quorum-sensing-controlled production of rhamnolipid by Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

High β-lactamase levels change the pharmacodynamics of β-lactam antibiotics in Pseudomonas aeruginosa biofilms

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2FDKU151

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42215035&oldid=2149688548"